Self-Screening for Neisseria gonorrhoeae and Chlamydia trachomatis in the Human Immunodeficiency Virus Clinic—High Yields and High Acceptability

Abstract

These findings highlight the need for the introduction of similar screening approaches in HIV clinics. Self-collected specimens using sensitive and specific GC and CT nucleic acid amplification tests are a convenient and acceptable way of testing, and it may address some of the barriers to screening in this population.

2016 United Kingdom national guideline on the sexual health care of men who have sex with men

“…There is evidence to suggest that self-collected pharyngeal and rectal swabs perform as well as clinician-taken swabs from both sites, although published studies are not powered to exclude a difference in performance. Self-taken swabs are highly acceptable to MSM (117)(118)(119).…”

Gonorrhoea and chlamydia screening in HIV clinics: time for new tools and targets

“…Extragenital screening can be expected to have a higher case detection yield (10%–20% of tests positive)1 2 12 than genital site screening, and extragenital site screening is clearly recommended by guidelines.…”

“…Time constraints are commonly brought up by doctors 14. Task shifting to nurses, patient self-collection and electronic reminders have yielded successes 1 2 8 15. Not surprisingly, sexual health specialists who provide HIV care outperform other HIV providers, screening 41% of MSM completely at urethral, rectal and oral sites compared with 6% complete screening by other providers in an Australian study 10.…”

Screening for asymptomatic lymphogranuloma venereum co-infection in men who have sex with men newly diagnosed with HIV, hepatitis C or syphilis

“…5 In this small sample size, no cases of LGV infection were identified; however, a high number of Chlamydia trachomatis infections were detected in HIV monoinfected patients (19%), higher than reported elsewhere (1.9-14.1%). [13][14][15][16] The finding that 5% of new HIV diagnosis were coinfected with either hepatitis C or syphilis re-enforces the recommendation for a comprehensive sexual health screening at diagnosis.…”